topへ

-【TRIDIG1317kr】

試験ステータス:参加者募集中

肝胆膵

登録期間:2015/2/5 から 2017/2/5

研究題目 Study on the efficacy and safety of autologous bone marrow cell infusion therapy in patients with cirrhosis due to hepatitis C virus
疾患名 C型肝炎ウイルス、肝硬変、細胞移植、骨髄幹細胞
登録状況 2 / 34
主任研究者 Kwang-Hyub Han
所属 Yonsei University
研究概要

【目的】
To investigate the efficacy and safety of autologous bone marrow cell infusion therapy to patients with cirrhosis caused by hepatitis C virus.
【選択規準】
(1) Cirrhosis caused by hepatitis C virus
(2) Cases of patients with a Child-Pugh score of 7 or higher (Child-Pugh B) at two time points separated by 90 days or longer, and those for whom it is not expected that symptoms will improve with current internal medicine therapy.
(3) Cases of patients aged 20 to 75 years, inclusive
(4) Cases from whom it is possible to obtain informed consent, and from whom consent to participate in the study is obtained
【主要評価項目】
The proportion of cases with an improvement in Child-Pugh score by 1 point or more in Week 24 after cell infusion for the Cell Infusion group, and in Week 24 after registration for the Standard Treatment group.

研究結果
関連論文
更新履歴

記事はありません。

キーワード